Market News & Trends
CureVac’s COVID-19 Vaccine Candidate Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant in Preclinical Challenge Study
CureVac N.V. recently announced the publication of preclinical data demonstrating that their COVID-19 vaccine candidate, CVnCoV, protects against challenge infections with the SARS-CoV-2 Variant of…
Dunad Therapeutics Emerges to Develop Next-Generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology
Dunad Therapeutics recently emerged to develop next-generation small molecule therapeutics based on its highly differentiated, tuneable, and targeted protein degradation technology. Dunad, secured initial financing…
Visus Therapeutics Initiates Phase 2 Clinical Trial for Presbyopia Treatment
Visus Therapeutics Inc. recently announced the commencement of its Phase 2 clinical trial of BRIMOCHOL topical ophthalmic solution under investigation for the treatment of presbyopia.…
AstraZeneca’s & J&J’s COVID-19 Vaccines Manufacturing Face Viral Vector Shortages
The latest wave of COVID-19 vaccines - those from AstraZeneca and Johnson & Johnson (J&J) - are recombinant vector vaccines, which are a different molecule…
Catalent Signs Drug Development Agreement With Cybin Inc
Catalent recently announced it has signed an agreement with Cybin Inc. to apply Catalent’s proprietary Zydis orally disintegrating tablet (ODT) technology for the delivery of…
IONTAS Identifies Novel SARS-CoV-2 Neutralizing Antibodies
IONTAS Limited and FairJourney Biologics S.A recently announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants. The results, generated from a…
Micropore Appoints Technology Distributor for Japanese Market
Award-winning UK-based particle engineering specialist Micropore Technologies has just announced the appointment of the Mutual Corporation as the representative for sales….
Aptar Pharma & Noble Partner With dne pharma on its Nasal Naloxone Treatment
Aptar Pharma and Noble, an Aptar Pharma company, recently announced their collaboration with dne pharma. Both companies are providing their nasal drug delivery….
Hovione Completes its Phase 2 Clinical Trial of the First Minocycline Ophthalmic
Hovione recently announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused….
Catalent Expands Partnership With Johnson & Johnson to Significantly Increase Capacity for Sterile Manufacturing & Packaging of COVID-19 Vaccine in Italy
Catalent recently announced an expanded partnership with Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent Biologics will significantly….
Axol Bioscience & Censo Biotechnologies Announce Merger
Axol Bioscience Ltd and CENSO Biotechnologies recently announced that the two companies have signed a merger agreement. The new entity will become a leading provider…
ProBioGen Licenses GlymaxX Technology to Sanofi
ProBioGen AG has recently signed a commercial multi-product license agreement with Sanofi. Under such agreement, Sanofi will integrate ProBioGen’s proprietary GlymaxX technology into their product development…
Timber Pharmaceuticals Announces 50% Enrollment in Phase 2b CONTROL Study
Timber Pharmaceuticals, Inc. recently announced 50% of patients in the Phase 2b CONTROL study evaluating TMB-001 (topical isotretinoin) in patients with moderate-to-severe congenital ichthyosis (CI)…
Owen Mumford Introduces 16-G Safety Lancet Into Unistik Touch Range for High-Volume Capillary Blood Sampling
Owen Mumford recently announced it has introduced a 16-gauge (16 G) safety lancet for high-volume capillary blood sampling into its leading Unistik product range. The…
FSD Pharma Enters License Agreement to Develop FDA-Approved Veterinary Drugs
FSD Pharma recently announced it has entered into a license agreement with Innovet Italia S.R.L., under which Innovet granted the company a license to use…
AC Immune Announces New Clinical Results in Down Syndrome, Plans for Future Development of Anti-Amyloid-Beta Vaccine
AC Immune SA recently announced plans to advance its novel anti-amyloid-beta (Abeta) vaccine into mid-stage clinical testing to treat and prevent the progression of Down…
Vetter Establishes Office in China to Better Serve the Needs of its Growing Customer Base Worldwide
Vetter, one of the global leaders in prefilled drug-delivery systems, recently announced the opening of a new business entity in Shanghai, China…..
Baxter BioPharma Solutions & Moderna Announce Manufacturing Agreement for Covid-19 Vaccine in the US
Baxter International Inc. and Moderna, Inc. recently announced they have entered into an agreement for Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and….
Metrics Contract Services Completes Russian Regulatory Inspection
Metrics Contract Services recently announced its Greenville, NC, facility has successfully completed an inspection by the Ministry of Industry and Trade of the Russian Federation for commercial manufacture of….
Vectura Expands Dry Powder Inhaler Development & Manufacturing Capabilities
Vectura Group plc, an industry leading inhalation CDMO, recently announced an expansion of its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, UK…..
